EWI-2 modulates lymphocyte integrin α4β1 functions

Blood

Volumn 103, Issue 8, 2004, Pages 3013-3019

  Kolesnikova, Tatiana V ^b   Stipp, Christopher S ^b   Rao, Ravi M ^b   Lane, William S ^b   Luscinskas, Francis W ^b   Hemler, Martin E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; CD9 ANTIGEN; CELL SURFACE PROTEIN; PROTEIN; PROTEIN EWI2; TETRASPANIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 1;

ARTICLE; CELL FUNCTION; CELL SPREADING; COMPLEX FORMATION; GEL PERMEATION CHROMATOGRAPHY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ISOLATION; SHEAR RATE; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY; WILD TYPE;

EID: 1842474884     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-07-2201     Document Type: Article

References (33)

1. Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA, Carter WG. Identification and characterization of the lymphocyte adhesion receptor for an alternative cell attachment domain in plasma fibronectin. J Cell Biol. 1989;109:1321-1330.
2. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 1990;60:577-584.
3. Lobb RR, Hemler ME. The pathophysiologic role of α4 integrins in vivo. J Clin Invest. 1994;94:1722-1728.
4. Postigo AA, Teixidó J, Sánchez-Madrid F. The α4β1/VCAM-1 adhesion pathway in physio-logy and disease. Res Immunol. 1993;144:723-735.
5. Yang JT, Rayburn H, Hynes RO. Cell adhesion events mediated by α4 integrins are essential in placental and cardiac development. Development. 1995;121:549-560.
6. Lin KC, Castro AC. Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents. Curr Opin Chem Biol. 1998;2:453-457.
7. Ghosh S, Goldin E, Gordon FH, et al. Natalizumab for active Crohn's disease. N Engl J Med. 2003;348:24-32.
8. Miller DH, Khan OA, Sheremata WA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2003;348:15-23.
9. Irie A, Kamata T, Puzon-Mclaughlin W, Takada Y. Critical amino acid residues for ligand binding are clustered in a predicted β-turn of the third N-terminal repeat in the integrin α4 and α5 subunits. EMBO J. 1995;14:5550-5556.
10. Pujades C, Alon R, Yauch RL, et al. Defining extracellular integrin α chain sites that affect cell adhesion and adhesion strengthening without altering soluble ligand binding. Mol Biol Cell. 1997;8:2635-2645.
11. Liu S, Rose DM, Han J, Ginsberg MH. Alpha4 integrins in cardiovascular development and diseases. Trends Cardiovasc Med. 2000;10:253-257.
12. Stipp CS, Kolesnikova TV, Hemler ME. EWI-2 is a major CD9 and CD81 partner, and member of a novel Ig protein subfamily. J Biol Chem. 2001;276:40545-40554.
13. Clark KL, Zeng Z, Langford AL, Bowen SM, Todd SC. Pgr1 is a major CD81-associated protein on lymphocytes and distinguishes a new family of cell surface proteins. J Immunol. 2001;167:5115-5121.
14. Pujades C, Teixidó J, Bazzoni G, Hemler ME. Integrin cysteines 278 and 717 modulate VLA-4 ligand binding and also contribute to α4/180 formation. Biochem J. 1996;313:899-908.
15. Fukudome K, Furuse M, Imai T, et al. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1) induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J Virol. 1992;66:1394-1401.
16. Pesando JM, Hoffman P, Conrad T. Malignant human B cells express two populations of p24 surface antigens. J Immunol. 1986;136:2709-2714.
17. Pear W, Nolan G, Scott M, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A. 1993;90:8392-8396.
18. Serru V, Naour FL, Billard M, et al. Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J. 1999;340:103-111.
19. Mannion BA, Berditchevski F, Kraeft S-K, Chen LB, Hemler ME, TM4SF proteins CD81 (TAPA-1), CD82, CD63 and CD53 specifically associate with α4β1 integrin. J Immunol. 1996;157:2039-2047.
20. Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion and fusion events, and define a novel type of membrane microdomain. Ann Rev Cell Dev Biol. 2003;19:397-422.
21. Skubitz KM, Campbell KD, Skubitz AP. CD63 associates with CD11/CD18 in large detergent-resistant complexes after translocation to the cell surface in human neutrophills. FESS Lett. 2000;469:52-56.
22. Feigelson SW, Grabovsky V, Shamri R, Levy S, Alon R. The CD81 tetraspanin facilitates instanteneous leukocyte VLA-4 adhesion strengthening to VCAM-1 under shear flow T. J Biol Chem. 2003;278:51203-51212.
23. Stipp CS, Kolesnikova TV, Hemler ME. EWI-2 regulates α3β1 integrin-dependent cell functions on laminin-5. J Cell Biol. 2003;163:1167-1177.
24. Kovalenko OV, Yang X, Kolesnikova TV, Hemler ME. Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteines available for crosslinking. Biochem J. 2004;377:407-417.
25. Zhang XA, Bontrager AL, Hemler ME. TM4SF proteins associate with activated PKC and link PKC to specific beta1 integrins. J Biol Chem. 2001;276:25005-25013.
26. Berditchevski F, Tolias KF, Wong K, Carpenter CL, Hemler ME. A novel link between integrins, TM4SF proteins (CD63, CD81) and phosphatidylinositol 4-kinase. J Biol Chem. 1997;272:2595-2598.
27. Yauch RL, Hemler ME. Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphatidylinositol 4-kinase. Biochem J. 2000;351:629-637.
28. Charrin S, Le Naour F, Oualid M, et al. The major CD9 and CD81 molecular partner: Identification and charcterization of the complexes. J Biol Chem. 2001;276:14329-14337.
29. Ticchioni M, Raimondi V, Lamy L, et al. Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow. FASEB J. 2001;15:341-350.
30. Lammerding J, Kazarov AR, Huang H, Lee RT, Hemler ME. Tetraspanin CD151 regulates alpha6beta1 integrin adhesion strengthening. Proc Natl Acad Sci U S A. 2003;100:616-7621.
31. Charrin S, Le Naour F, Labas V, et al. EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem J. 2003;373:409-421.
32. Stipp CS, Orlicky D, Hemler ME. FPRP: a major, highly stoichiometric, highly specific CD81 and CD9-associated protein. J Biol Chem. 2001;276:4853-4862.
33. Liu S, Thomas SM, Woodside DG, et al. Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses. Nature. 1999;402:676-681.